34- Physician-Investor Series: Morgan Cheatham MD Candidate (Bessemer Venture Partners)

Episode 34 December 21, 2022 00:46:28
34- Physician-Investor Series: Morgan Cheatham MD Candidate (Bessemer Venture Partners)
Physicians Off The Beaten Path
34- Physician-Investor Series: Morgan Cheatham MD Candidate (Bessemer Venture Partners)

Dec 21 2022 | 00:46:28

/

Hosted By

Alexey Youssef Shad Faraz

Show Notes

How to venture early off the beaten path? How to gain multiple skills and still focus on investments in healthcare and life sciences from early to growth stages? How to venture in the domain of healthcare technologies and accumulate experience in heakthcare IT startups?

And many more questions are to be answered in today's episode with Morgan Cheatham.

Cheatham. Morgan is a Vice President at Bessemer Venture Partners, a global venture capital firm with over $19 billion in assets under management, where he focuses on investments in healthcare.

Morgan was accepted to medical school at age 17 and was working as a data scientist at a healthcare startup by age 19. Morgan is pursuing his medical degree at The Warren Alpert Medical School of Brown University and graduated magna cum laude from Brown University with a B.S. in neuroeconomics

Recently, Morgan was featured on Forbes List 30 Under 30 for Venture Capital (2023).

If you've found our podcast helpful, buy us a coffee

Other Episodes

Episode 1

June 14, 2021 00:42:26
Episode Cover

01- Physician-Investor Series: Venture Capital Partner Dan Gebremedhin (Flare Capital)

Have you ever wondered about the investing world? In our inaugural episode, we talk to Dr. Dan Gebremedhin, a venture capital partner at Flair...

Listen

Episode 26

June 15, 2022 00:51:30
Episode Cover

26- Physician-Executive Series: Alex Ding, MD (Humana)

What are the most important things you need to have in order to succeed in a nontraditional path? How can you keep evolving in...

Listen

Episode 28

July 13, 2022 00:48:24
Episode Cover

28- Physician-Scientist Series: Shaheen Lakhan, MD (Click Therapeutics)

What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about...

Listen